MTI (TSE:9438) ROCE %: 18.50% (As of Mar. 2026)


TSE:9438 MTI Ltd TSE:9438
67 GF Score
Price 円534.00
GF Value 円847.15
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is MTI ROCE %?

MTI TSE:9438 -0.37% 67 ROCE % is 18.50% as of Mar. 2026. GuruFocus rates TSE:9438 with a GF Score™ of 67/100 and a GF Value™ of 円847.15 (Significantly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MTI's annualized ROCE % for the quarter that ended in Mar. 2026 was 18.50%.

MTI  (TSE:9438) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MTI ROCE % Related Terms

MTI ROCE % Historical Data

* Premium members only.

The historical data trend for MTI's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MTI ROCE % Chart

MTI Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 -1.24 5.41 15.51 19.48

MTI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.67 10.72 24.05 14.69 18.50
TSE:9438
67GF Score
MTI Ltd TSE:9438
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MTI ROCE % Calculation

MTI's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2025 )  (A: Sep. 2024 )(A: Sep. 2025 )
=4676.662/( ( (29686.449 - 6951.519) + (33347.754 - 8074.19) )/ 2 )
=4676.662/( (22734.93+25273.564)/ 2 )
=4676.662/24004.247
=19.48 %

MTI's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=4733.364/( ( (31632.534 - 6378.77) + (31979.304 - 6050.558) )/ 2 )
=4733.364/( ( 25253.764 + 25928.746 )/ 2 )
=4733.364/25591.255
=18.50 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 18.50% mean?
MTI (TSE:9438) has a ROCE % of 18.50% as of Mar. 2026.
Is MTI's ROCE % too high?
MTI's current ROCE % is 18.50%. The Healthcare Providers & Services industry median ROCE % is 6.43. MTI's value of 18.50% is 187.7% above this industry median. Overall, MTI has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MTI's ROCE % compare to VEEV and BTSG?
MTI's ROCE % of 18.50% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. MTI's value of 18.50% is 187.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MTI's current ROCE % of 18.50% is 187.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MTI's current ROCE % is 18.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MTI stock overvalued right now?
Based on GuruFocus' analysis, MTI (TSE:9438) is currently considered Significantly Undervalued. The stock's GF Value™ is 円847.15, compared to a current price of 円534.00 — trading 37% below its estimated fair value. The current ROCE % is 18.50% and 187.7% above the Healthcare Providers & Services industry median of 6.43. MTI's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For MTI (TSE:9438), the current ROCE % is 18.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MTI (TSE:9438) Overvalued in 2026?

Based on GuruFocus' analysis, MTI stock appears to be undervalued. The current stock price of 円534.00 is trading 37% below its estimated GF Value™ of 円847.15. GuruFocus considers MTI to be Significantly Undervalued.

Key valuation signals for TSE:9438:

  • ROCE %: 18.50%
  • GF Value™: 円847.15 vs. price of 円534.00 (37% below fair value)
  • GF Score™: 67/100 with 1 warning sign
  • Industry Position: 187.7% above the Healthcare Providers & Services median

No single metric tells the full story. See the TSE:9438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MTI Business Description

Address 35th Floor, Tokyo Opera City Tower 3-20-2, Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-1435
MTI Ltd is engaged in the content distribution business for mobile phones in Japan. The company provides health care services through Lunaruna app, Lunaruna baby, and Lunaruna medicine notebook. It is involved in providing music/video services, electronic book services, life information services, and entertainment services.
67GF Score

Get the complete analysis for TSE:9438

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円534.00
Price
円847.15
GF Value